[1]
Demirelli, B. 2025. Renal and Hemodynamic Effects of Sodium-Glucose Cotransporter 2 Inhibitors in Patients with Type 2 Diabetes and Chronic Kidney Disease Receiving Varying Doses of Renin-Angiotensin System Blockade: Renal and Hemodynamic Effects of SGLT2i. Journal of European Internal Medicine Professionals. 3, 3 (Aug. 2025), 117–123. DOI:https://doi.org/10.5281/zenodo.16737200.